The Ultimate Guide to Pazopanib 400mg (Targeted Cancer Therapy): In the evolving field of precision medicine, Pazopanib 400 mg Tablets have emerged as a vital therapeutic option for patients battling advanced cancers. As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this high-quality tyrosine kinase inhibitor (TKI) is accessible to healthcare providers and distributors in London, New York, Sydney, Johannesburg, and across the globe. Product Specifications & Fast Facts Brand Name: Ernest-Oncology (Pazopanib Hydrochloride) Strength: 400 mg per tablet Dosage Form: Oral Tablet (Film-coated) Primary Indications: Advanced Renal Cell Carcinoma (RCC) and Soft Tissue Sarcoma (STS) Storage: Store at room temperature (20°C to 25°C), away from moisture and direct light. Mechanism of Action: How It Works Anti-Angiogenesis: It primarily inhibits the Vascular Endothelial Growth Factor Receptor (VEGFR). By doing so, it prevents the tumor from growing new blood vessels, effectively “starving“ the tumor of the oxygen and nutrients it needs to grow. Targeting Growth Signals: It also blocks other key receptors, including PDGFR (Platelet-Derived Growth Factor Receptor) and FGFR (Fibroblast Growth Factor Receptor), which are involved in cell proliferation and survival. Halting Metastasis: By inhibiting these pathways, Pazopanib slows down the spread of cancer cells to other parts of the body. Therapeutic Indications & Administration Advanced Renal Cell Carcinoma (RCC): For patients with advanced kidney cancer. Advanced Soft Tissue Sarcoma (STS): For patients who have previously received chemotherapy. Proper Administration Guidelines: Empty Stomach Requirement: For maximum efficacy, Pazopanib must be taken on an empty stomach—at least 1 hour before or 2 hours after a meal. Whole Tablet: Do not crush, break, or chew the tablet. Swallowing it whole prevents the drug from being absorbed too quickly, which can increase side effects. Avoid Grapefruit: Patients should not consume grapefruit or grapefruit juice, as it can dangerously increase the levels of pazopanib in the bloodstream. Clinical Side Effects & Safety Hepatotoxicity: Pazopanib can cause severe liver damage. Regular liver function tests (ALT, AST, and bilirubin) are mandatory. Cardiovascular Risks: It may lead to hypertension (high blood pressure), heart failure, or QT prolongation (irregular heart rhythm). Gastrointestinal Issues: Common effects include diarrhea, nausea, vomiting, and decreased appetite. Appearance Changes: Patients often experience a characteristic change in hair color (depigmentation/lightening) or skin lightening. Serious Warnings: It can interfere with wound healing and increase the risk of bleeding or gastrointestinal perforation. Why Source from Ernest Oncology? United Kingdom (London): Providing cost-effective alternatives for private oncology centers and healthcare networks. USA: Supplying bulk quantities that meet stringent safety and documentation benchmarks. Australia: Facilitating access via regulatory pathways such as the “Special Access Scheme“ (SAS). South Africa: Bridging the gap in cancer care with high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us